MHRA approves Retifanlimab (ZYNYZ) for the treatment of advanced anal cancer

Publisher excerpt

The Medicines and Healthcare products Regulatory Agency (MHRA) has approved retifanlimab (ZYNYZ) for the treatment of adults with squamous cell carcinoma of the anal canal...

Keywords

MHRA · Retifanlimab · ZYNYZ · treatment · anal · advanced · cancer

Visit publisher ↗

More in World News

Global Voices · Nov 13, 2026 · Luis Carlos Diaz

How medical neglect killed Alfredo Díaz in a Venezuelan cell

Story details →

GOV.UK · Nov 13, 2026

More than 80,000 knives taken off the streets

Knife-enabled robbery down 24% across the 7 most affected police forces.

Story details →

New Zealand Government · Nov 12, 2026 · beehive.govt.nz

NZ to attend APEC and East Asia Summit

New Zealand will be represented by Prime Minister Christopher Luxon and Trade and Investment Minister Todd McClay at the APEC Leaders’ Meeting in China and...

Story details →

Global Voices · Nov 12, 2026 · Janine Mendes-Franco

Trinbagonian Jason Jones wins landmark Privy Council judgement deeming ‘buggery laws’ unconstitutional

Story details →